Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
Open Access
- 1 May 2008
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 123
- https://doi.org/10.1186/1471-2407-8-123
Abstract
Hypoxia influences tumor growth by inducing angiogenesis and genetic alterations. Hypoxia-inducible factor 1α (HIF-1α), p53, and vascular endothelial growth factor (VEGF) are all important factors in the mechanisms inherent to tumor progression. In this work, we have investigated the clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF (sVEGF) level in gastric cancer. We immunohistochemically assessed the HIF-1α, p53, and VEGF expression patterns in 114 specimens of gastric cancer. Additionally, we determined the levels of preoperative serum VEGF (sVEGF). The positive rates of p53 and HIF-1α (diffuse, deep, intravascular pattern) were 38.6% and 15.8%, respectively. The VEGF overexpression rate was 57.9%. p53 and HIF-1α were correlated positively with the depth of invasion (P = 0.015, P = 0.001, respectively). Preoperative sVEGF and p53 levels were correlated significantly with lymph node involvement (P = 0.010, P = 0.040, respectively). VEGF overexpression was more frequently observed in the old age group (≥ 60 years old) and the intestinal type (P = 0.013, P = 0.014, respectively). However, correlations between preoperative sVEGF level and tissue HIF-1α, VEGF, and p53 were not observed. The median follow-up duration after operation was 24.5 months. HIF-1α was observed to be a poor prognostic factor of disease recurrence or progression (P = 0.002). p53, HIF-1α and preoperative sVEGF might be markers of depth of invasion or lymph node involvement. HIF-1α expression was a poor prognostic factor of disease recurrence or progression in patients with gastric cancers.Keywords
This publication has 31 references indexed in Scilit:
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Relation of Hypoxia-Inducible Factor-1?? to Vascular Endothelial Growth Factor and Vasoactive Factors During Healing of Gastric UlcersJournal of Cardiovascular Pharmacology, 2004
- Hypoxia-Inducible Factor 1? Expression Correlates with Angiogenesis and Unfavorable Prognosis in Bladder CancerEuropean Urology, 2004
- Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric CancerClinical Cancer Research, 2004
- The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancerCancer Letters, 2003
- Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinomaInternational Journal of Cancer, 2003
- Amplification of hypoxia-inducible factor 1α gene in prostate cancerCancer Genetics and Cytogenetics, 2001
- Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian CellsMolecular and Cellular Biology, 2001
- Relationship of p53 and Vascular Endothelial Growth Factor Expression to Clinicopathological Factors in Human Scirrhous Gastric CancerEuropean Surgical Research, 1998
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996